NOVEMBER 2023LIFE SCIENCES REVIEW518CXO INSIGHTSCXO INSIGHTSGeneric Drug Products Development ­ Challenges and OverviewSuci Ameliya Reza Zairizal, Associate Manager, Novugen24A Glimpse into the Future of Rare Diseases Drug Development: The Latest Advances and InnovationsSafwan Kezbor, M.D. ­ Senior Medical Director, Clinical Development, Shionogi28Ensuring Safe Drug Development with Regulatory ComplianceEnrique Blanco, Gral Director / Director OfCorp Operations, Grupo Loeffler-Russek20Speed, Safety and Scalability: An Integrative Approach to Drug DevelopmentLinda Cherry, Vice President, and Doug Niven, Executive Director, Strategic Solutions, Syneos Health26Microbiological Considerations for Achieving Drug Manufacturing ExcellenceJessica Wilson Rayse, Assoc Director of Product Management, Accugenix, Charles River LaboratoriesDrug Safety and Pharmacovigilance InsightsJosefina Mendoza, Pharmacovigilance Alliance LATAM & Head of Drug Safety CAMEX, Grunenthal22PG 16ANTIBODY DRUGDISCOVERYTOP 10SOLUTIONS PROVIDERS - 2023
< Page 4 | Page 6 >